1201 related articles for article (PubMed ID: 23523418)
1. Preoperative use of anti-TNF therapy and postoperative complications in inflammatory bowel diseases: a meta-analysis.
Billioud V; Ford AC; Tedesco ED; Colombel JF; Roblin X; Peyrin-Biroulet L
J Crohns Colitis; 2013 Dec; 7(11):853-67. PubMed ID: 23523418
[TBL] [Abstract][Full Text] [Related]
2. Risk of postoperative infectious complications from medical therapies in inflammatory bowel disease.
Law CC; Bell C; Koh D; Bao Y; Jairath V; Narula N
Cochrane Database Syst Rev; 2020 Oct; 10(10):CD013256. PubMed ID: 33098570
[TBL] [Abstract][Full Text] [Related]
3. Systematic Review and Meta-Analysis: Preoperative Vedolizumab and Postoperative Complications in Patients with IBD.
Moosvi Z; Duong JT; Bechtold ML; Nguyen DL
South Med J; 2021 Feb; 114(2):98-105. PubMed ID: 33537791
[TBL] [Abstract][Full Text] [Related]
4. Systematic review and meta-analysis: risks of postoperative complications with preoperative use of anti-tumor necrosis factor-alpha biologics in inflammatory bowel disease patients.
Moosvi Z; Duong J; Bechtold ML; Nguyen DL
Eur J Gastroenterol Hepatol; 2021 Jun; 33(6):799-816. PubMed ID: 33079779
[TBL] [Abstract][Full Text] [Related]
5. The impact of preoperative steroid use on short-term outcomes following surgery for inflammatory bowel disease.
Nguyen GC; Elnahas A; Jackson TD
J Crohns Colitis; 2014 Dec; 8(12):1661-7. PubMed ID: 25107847
[TBL] [Abstract][Full Text] [Related]
6. Increased Risk of Infections with Anti-TNF Agents in Patients with Crohn's Disease After Elective Surgery: Meta-Analysis.
Hanzel J; Almradi A; Istl AC; Yang ML; Fleshner KA; Parker CE; Guizzetti L; Ma C; Singh S; Jairath V
Dig Dis Sci; 2022 Feb; 67(2):646-660. PubMed ID: 33634430
[TBL] [Abstract][Full Text] [Related]
7. Preoperative immunosuppression is not associated with increased postoperative complications following colectomy in children with colitis.
Schaufler C; Lerer T; Campbell B; Weiss R; Cohen J; Sayej W; Hyams J
J Pediatr Gastroenterol Nutr; 2012 Oct; 55(4):421-4. PubMed ID: 22395189
[TBL] [Abstract][Full Text] [Related]
8. Impact of antitumour necrosis factor therapy on surgery in inflammatory bowel disease: a population-based study.
Hawthorne AB; Arms-Williams B; Cannings-John R; Pollok RCG; Berry A; Harborne P; Trivedi A
BMJ Open Gastroenterol; 2024 May; 11(1):. PubMed ID: 38777566
[TBL] [Abstract][Full Text] [Related]
9. Preoperative Use of Methotrexate and the Risk of Early Postoperative Complications in Patients with Inflammatory Bowel Disease.
Afzali A; Park CJ; Zhu K; Hu JK; Sharma P; Sinanan MN; Lee SD
Inflamm Bowel Dis; 2016 Aug; 22(8):1887-95. PubMed ID: 27057681
[TBL] [Abstract][Full Text] [Related]
10. Postoperative Outcomes in Vedolizumab-Treated Patients Undergoing Abdominal Operations for Inflammatory Bowel Disease.
Lightner AL; Raffals LE; Mathis KL; Cima RR; Tse CS; Pemberton JH; Dozois EJ; Loftus EV
J Crohns Colitis; 2017 Feb; 11(2):185-190. PubMed ID: 27543504
[TBL] [Abstract][Full Text] [Related]
11. Cumulative incidence of, risk factors for, and outcome of dermatological complications of anti-TNF therapy in inflammatory bowel disease: a 14-year experience.
Fréling E; Baumann C; Cuny JF; Bigard MA; Schmutz JL; Barbaud A; Peyrin-Biroulet L
Am J Gastroenterol; 2015 Aug; 110(8):1186-96. PubMed ID: 26195181
[TBL] [Abstract][Full Text] [Related]
12. Psoriasis and Psoriasiform Eruptions in Pediatric Patients with Inflammatory Bowel Disease Treated with Anti-Tumor Necrosis Factor Alpha Agents.
Eickstaedt JB; Killpack L; Tung J; Davis D; Hand JL; Tollefson MM
Pediatr Dermatol; 2017 May; 34(3):253-260. PubMed ID: 28211161
[TBL] [Abstract][Full Text] [Related]
13. Risk of Postoperative Complications Among Inflammatory Bowel Disease Patients Treated Preoperatively With Vedolizumab.
Yamada A; Komaki Y; Patel N; Komaki F; Aelvoet AS; Tran AL; Pekow J; Dalal S; Cohen RD; Cannon L; Umanskiy K; Smith R; Hurst R; Hyman N; Rubin DT; Sakuraba A
Am J Gastroenterol; 2017 Sep; 112(9):1423-1429. PubMed ID: 28719595
[TBL] [Abstract][Full Text] [Related]
14. Associations Between Obesity and the Effectiveness of Anti-Tumor Necrosis Factor-α Agents in Inflammatory Bowel Disease Patients: A Literature Review and Meta-analysis.
Dai ZH; Xu XT; Ran ZH
Ann Pharmacother; 2020 Aug; 54(8):729-741. PubMed ID: 31955605
[No Abstract] [Full Text] [Related]
15. Therapeutic management of inflammatory bowel disease in real-life practice in the current era of anti-TNF agents: analysis of the French administrative health databases 2009-2014.
Kirchgesner J; Lemaitre M; Rudnichi A; Racine A; Zureik M; Carbonnel F; Dray-Spira R
Aliment Pharmacol Ther; 2017 Jan; 45(1):37-49. PubMed ID: 27781286
[TBL] [Abstract][Full Text] [Related]
16. Management of inflammatory bowel disease with infliximab and other anti-tumor necrosis factor alpha therapies.
Magro F; Portela F
BioDrugs; 2010 Dec; 24 Suppl 1():3-14. PubMed ID: 21175228
[TBL] [Abstract][Full Text] [Related]
17. Pre-operative use of anti-TNF-α agents and the risk of post-operative complications in patients with ulcerative colitis - a nationwide cohort study.
Nørgård BM; Nielsen J; Qvist N; Gradel KO; de Muckadell OB; Kjeldsen J
Aliment Pharmacol Ther; 2012 Jun; 35(11):1301-9. PubMed ID: 22506582
[TBL] [Abstract][Full Text] [Related]
18. Anti-tumor necrosis factor therapy is associated with infections after abdominal surgery in Crohn's disease patients.
Syed A; Cross RK; Flasar MH
Am J Gastroenterol; 2013 Apr; 108(4):583-93. PubMed ID: 23481144
[TBL] [Abstract][Full Text] [Related]
19. Safety Analysis of Preoperative Anti-TNF-α Therapy in Pediatric IBD After Intestinal Resection: A Systematic Review and Meta-analysis.
Bajzát D; Kéri AF; Imrei M; Kói T; Párniczky A; Hegyi P; Kovács K; Váncsa S; Müller KE
Inflamm Bowel Dis; 2023 Dec; 29(12):1971-1980. PubMed ID: 36789751
[TBL] [Abstract][Full Text] [Related]
20. Anti-TNF-alpha therapies do not increase early postoperative complications in patients with inflammatory bowel disease. An Italian single-center experience.
Rizzo G; Armuzzi A; Pugliese D; Verbo A; Papa A; Mattana C; Rapaccini GL; Guidi L; Coco C
Int J Colorectal Dis; 2011 Nov; 26(11):1435-44. PubMed ID: 21594668
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
